article 17.9.4 of the United States- Australia Free Trade Agreement implementing legislation allowing patent holders to prevent the import of their patented products is redundant and should not have been included in the agreement. Australian law already bans the export of pharmaceuticals if such drugs are purchased under its Pharmaceutical Benefits Scheme, PBS, and PBS drugs account for over 90 percent of all drugs sold in Australia. This language does not establish a precedent for other free trade agreements. According to the Senate Finance Committee, it is appropriate to raise objections if this language is included in a free trade agreement negotiated with a country that does not forbid the export of low cost pharmaceuticals. Therefore, I will support this agreement.
Mike Levin: “article 17.9.4 of the United States- Australia Free Trade Agreement implementing legislation allowing patent holders to…”
Editor's note · Context
Discussing the United States-Australia Free Trade Agreement and its implications for pharmaceutical exports.
Share
More from Mike Levin
Congress must now work in a bipartisan, bicameral fashion to authorize the Nuclear Lifecycle Innovation Campuses and write them into law with clear oversight, clear benchmarks, and clear connections to permanent disposal.
We need a substantial increase in research funding to determine the appropriate care and resources for our troops and veterans, and I will continue to fight for that on the House Appropriations Committee.
When Michaelle’s son Tristan was diagnosed with an ultra-rare genetic condition, she and her husband, Kevin, refused to accept that there was nothing to be done.
None of this is easy. It demands a more principled, inclusive, and constructive kind of American leadership than the one we have now.





